4 Big Names – Result Wrap (QBE, DOW, IVC, ASX)

4 Big Names – Result Wrap

QBE Insurance Group Limited (ASX: QBE), under the financial services, provides for underwriting of general and reinsurance risks. The stock traded at a market price of $10.89 with a daily price change of $0.69 or a percentage change of 6.76% on August 16, 2018 and the stock has seen a performance change of -13.56% over the past 12 months. Accompanied by the premium growth, fewer weather catastrophes, and rate increases, QBE has reported a rise in interim profit. Compared to the same period last year for the six months ended June 30, net profit rose 4 percent to $US370 million ($511.2 million), and this number excludes the Latin America business of QBE. However, the total revenue declined to the US $7.3 billion which is down by 6 percent, but the cash net profit was up 3 percent. Due to mark-to-market losses in QBE’s fixed interest portfolio and lower returns from growth assets, investment returns slid to $US287 million in the half from $US424 million.

Downer EDI Limited (ASX: DOW) is  a known name in the industrial sector. The stock was trading flat at a market price of $7.51 with an initial daily price change of $0.035 or a percentage change of 0.466% on August 16, 2018. The stock has seen a performance change of 10.28% over the past 12 months. As annual net profit slid to $71.4 million down by 61 percent due to a strip of one-off items, Downer chief said that the contractor hoped to restructure its contract of Royal Adelaide Hospital. In its mining business, EBITDA fell to $50.4 million which is down by 40 percent. The group’s revenue rose to $12 billion, by 65%.

Invocare Limited (ASX: IVC) under the consumer discretionary sector, is a leading provider of services relating to funerals, burials, and cremations. The stock traded at a market price of $13.14 with a daily price change of -$1.26 or a percentage change of -8.75% on August 16, 2018 and the stock has seen a performance change of 1.55% over the past 12 months. As death rates fall below usual trends, Invocare has cut its interim dividends given the hit to its performance. The company has a market share of 33 percent in Australia and is among key shorted stocks. 30 percent above the expectations, Invocare was producing earnings from the revamped sites. Net profit after tax dropped by 50 percent to $ 20.9 million for the six months period ending June 30, 2018. Total revenue was up to $223.7 million which is up by 2.5 percent. Operating earnings after tax was down to $23.5 million which is 7.4 percent.

ASX Limited (ASX: ASX) saw its stock trading at a market price of $68.18 near its 52-week high, with a daily price change of $0.350 or a percentage change of 0.516% on August 16, 2018 and the stock has seen a performance change of 26.79% over the past 12 months. The underlying net profit is up to $465.3 million which is up 7.2 percent, and has been led by a 75 percent jump in the amount of capital raised in IPOs and more trading in future market. The revenue was up by 7.7 percent to $823 million which is the highest in 8 years. In the 2019 financial year, ASX is expecting expenses to be up 9 percent. With the secondary data center and other projects, the capex went up to $54.1 million for the year. The full year dividend was 7 percent higher to $2.16.

Dividend Stocks To Buy

The Income available from dividends remains attractive for many investors.

We take a look at the best yields on the market and assess what they say about a company’s prospect.

One Thing is certain, though, Australia interest rates are still low, making income difficult to come by and keeping the focus for many investors on high yielding stocks. Kalkine’s team of analysts bought you handpicked report for “Top 25 Dividend Stocks For 2018.”

ASX-relevant Special Reports are published year-round to provide a detailed analysis into an investing opportunity or a potential risk to your portfolio.

Click here to get your free report.


Disclaimer

The advice given by Kalkine Pty Ltd and provided on this website is general information only and it does not take into account your investment objectives, financial situation or needs. You should therefore consider whether the advice is appropriate to your investment objectives, financial situation and needs before acting upon it. You should seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice) as necessary before acting on any advice. Not all investments are appropriate for all people. Kalkinemedia.com and associated websites are published by Kalkine Pty Ltd ABN 34 154 808 312 (Australian Financial Services License Number 425376). website), employees and/or associates of Kalkine Pty Ltd do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations.

Join Our Discussion

Start discussion with value Investors for ASX Stock Market Investment and Opinion.


6 Cannabis Stocks under Investor’s Limelight…

Cannabis companies that sell both medicinal weed and recreational pot. Marijuana stocks to look at. Marijuana mergers and acquisitions. Dispensary data analytics. Upcoming marijuana IPO’s Those phrases have become increasingly common as marijuana legalization spreads.

Global spending on legal cannabis is expected to grow 230% to $32 billion in 2020 as compared to $9.5 in 2017, according to Arcview Market Research and BDS Analytics. As of June 29, 2018 the United States Marijuana Index, despite a lot of uncertainty around regulations, has over the past 1 year gained 71.49%, as compared to about 12% gain seen by the S&P 500.

Click here for your FREE Report